AbbVie Inc logo

AbbVie Inc

€ 153.74 (+0.2%) Dec 2
P/E:
21.85
P/B:
18.10
Market Cap:
€ 274.91B ($ 289.78B)
Enterprise V:
€ 329.74B ($ 347.58B)
Volume:
2.00
Avg Vol (2M):
35.00
Also Trade In:
Volume:
2.00
Market Cap €:
274.91B
Market Cap $:
289.78B
PE Ratio:
21.85
Avg Vol (2-Month):
35.00
Enterprise Value €:
329.74B
Enterprise Value $:
347.58B
PB Ratio:
18.10
GF Score:
Year:
Not Enough Data to Display
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Not Enough Data to Display
Alerts Website Sources Stock Report
Dataset
Financial Download

Business Description

Description
AbbVie is a pharmaceutical company with a strong exposure to immunology and oncology. The firm's top drug, Humira, represents close to half of the company's current profits. The company was spun off from Abbott in early 2013. The recent acquisition of Allergan adds several new drugs in aesthetics and women's health.

Financials (Next Earnings Date:2023-02-02 Est.)

WBO:ABBV's 30-Y Financials

Guru Trades

See Details
To
Not Enough Data to Display

Insider Trades

See Details
To
Not Enough Data to Display

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
Not Enough Data to Display

Performance

Dividend
Log
To
Not Enough Data to Display

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Not Enough Data to Display

Valuation Box

Year:
Not Enough Data to Display

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 54,222.252
EPS (TTM) (€) 6.993
Beta 0
Volatility % 23.81
14-Day RSI 58.85
14-Day ATR (€) 1.833084
20-Day SMA (€) 150.259
12-1 Month Momentum % 43.9
52-Week Range (€) 103.5 - 160.9
Shares Outstanding (Mil) 1,768.48

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 8
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

AbbVie Inc Filings

Document Form Filing Date
No Filing Data

AbbVie Inc Analysis

Share your research